| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/14/2007 | US7255868 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies |
| 08/14/2007 | CA2354047C Method for the treatment of inflammation |
| 08/14/2007 | CA2332514C Broad spectrum microbicidal and spermicidal compositions, devices and methods |
| 08/10/2007 | CA2572764A1 Local system for the release of active principle and process for its manufacture |
| 08/09/2007 | WO2007090123A2 Mgra is a redox regulator of antibiotic sensitivity and virulence |
| 08/09/2007 | WO2007089150A1 Means and methods for influencing interactions between dc-sign and dc-sign ligands |
| 08/09/2007 | WO2007089133A1 Means and methods for influencing interactions between dc-sign and dc-sign ligands |
| 08/09/2007 | WO2007089030A1 Use of 6-(3-chloro-2-fluorobenzyl)-1-[(2s)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection |
| 08/09/2007 | WO2007088830A1 Novel peptide and therapeutic agent for endotoxin-induced disease using the same |
| 08/09/2007 | WO2007088478A1 Indazole oxazolidinones as antibacterial agents |
| 08/09/2007 | WO2007088438A2 Benzisoxazole oxazolidinones as antibacterial agents |
| 08/09/2007 | WO2007088214A2 Treating hiv infection, wherein hiv has a k65r mutation |
| 08/09/2007 | WO2007088196A1 Use of alkylglucoside esters as beta-defensin inducers |
| 08/09/2007 | WO2007088148A1 Derivatives of thiophene carboxilic acid as antiviral agent |
| 08/09/2007 | WO2007087825A1 Use of a combination of ethanolic rosa sp . , urtica dioica and tanacetum vulgare extracts, further comprising selenium and urea and having been exposed to a pulsed electromagnetic field, for the preparation of a medicament for immunostimulation and/or treatment of hiv infections |
| 08/09/2007 | WO2007087717A1 Viral polymerase inhibitors |
| 08/09/2007 | WO2007057678A3 Pathogen - controlling products |
| 08/09/2007 | WO2007054283A3 Pqs and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 08/09/2007 | WO2007053194A3 Modulation of cell barrier dysfunction |
| 08/09/2007 | WO2006130688A3 Compounds for inhibiting cathepsin activity |
| 08/09/2007 | WO2006125048A3 Hiv-integrase inhibitor compounds |
| 08/09/2007 | WO2006117217A3 Novel use of spiegelmers |
| 08/09/2007 | US20070185174 Use of thiazole derivatives for preparing a medicament intended to protect the mitochondria |
| 08/09/2007 | US20070185170 1,1'-(benzene-1,3-diylmethylene)bis[4-(4-chloro-N-methylanilino)pyridinium]dibromide, that inhibit phosphorylcholine biosynthesis by selective blocking of the choline kinase enzyme in tumor cells or in cells affected by parasitic infections; anticarcinogenic or antitumor agents; fungicides; viricides |
| 08/09/2007 | US20070185169 2-Mercapto-4,5-Diarylimidazole Derivatives and the use thereof as Cyclooxygenase Inhibitors |
| 08/09/2007 | US20070185157 Tropane derivatives useful in therapy |
| 08/09/2007 | US20070185151 Azabicyclic, azatricyclic and azaspirocyclic derivatives of aminocyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 08/09/2007 | US20070185132 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereo |
| 08/09/2007 | US20070185121 Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents |
| 08/09/2007 | US20070185112 Piperidine/piperazine-type inhibitors of p38 kinase |
| 08/09/2007 | US20070185037 Sulfated oligosaccharide derivatives |
| 08/09/2007 | US20070185022 Therapeutic composiitons comprising bactericidal/permeability-increasing (BPI) protein products |
| 08/09/2007 | US20070185011 Individual is not exposed to C1INH for longer than required, since levels of the C1INH more rapidly subsides after administration has stopped; side effect reduction |
| 08/09/2007 | US20070185007 Inhibition of HiV integrase compounds |
| 08/09/2007 | US20070184477 Anti-HIV Agent |
| 08/09/2007 | US20070184435 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 08/09/2007 | US20070184151 Use of a polyamine-poor composition for the production of a medical human food |
| 08/09/2007 | US20070184125 Use of extracts from gentiana lutea as an antimicrobial agent |
| 08/09/2007 | US20070184114 Formulation for topical non-invasive application in vivo |
| 08/09/2007 | US20070184070 Recombinant toxin fragments |
| 08/09/2007 | US20070184058 Glucocerebroside treatment of pulmonary or respiratory diseases or disorders |
| 08/09/2007 | US20070184022 Microsome vaccine |
| 08/09/2007 | US20070183983 Medical composition containing nf-kb decoy for treating and preventing respir atory diseases and method of using the same |
| 08/09/2007 | US20070181124 Method and apparatus for dispensing inhalator medicament |
| 08/09/2007 | CA2640584A1 Cationic steroid antimicrobial compositions and methods of use |
| 08/09/2007 | CA2638784A1 Viral polymerase inhibitors |
| 08/09/2007 | CA2637811A1 Benzisoxazole oxazolidinones as antibacterial agents |
| 08/09/2007 | CA2622679A1 Immunostimulatory single-stranded ribonucleic acid with phosphodiester backbone |
| 08/09/2007 | CA2577468A1 Composition and method for pre-surgical skin disinfection |
| 08/08/2007 | EP1816200A1 Postweaning multisystemic wasting syndrome virus for pigs |
| 08/08/2007 | EP1816198A1 Variable fragments of immunoglobulins-use for therapeutic or veterinary purposes |
| 08/08/2007 | EP1816138A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 08/08/2007 | EP1816122A2 3,4,5-substituted piperidines as therapeutic compounds |
| 08/08/2007 | EP1815868A2 Drug absorptivity improving agent |
| 08/08/2007 | EP1815861A2 Ionene polymers and their use as antimicrobial agents |
| 08/08/2007 | EP1814989A2 Methods and compositions for rna interference |
| 08/08/2007 | EP1814907A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 08/08/2007 | EP1814867A2 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents |
| 08/08/2007 | EP1814861A1 Substituted 5-oxo pyrazoles and [1,2,4]triazoles as antiviral agents |
| 08/08/2007 | EP1814860A1 Substituted 5-carboxyamide pyrazoles and [1,2,4]triazoles as antiviral agents |
| 08/08/2007 | EP1814596A2 Antisense antiviral compounds and methods for treating filovirus infection |
| 08/08/2007 | EP1814577A2 Use of baff to treat sepsis |
| 08/08/2007 | EP1814566A2 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds |
| 08/08/2007 | EP1814561A2 Therapeutic furopyrimidines and thienopyrimidines |
| 08/08/2007 | EP1814549A2 Method for treating hiv infection through co-administration of tipranavir and uk-427, 857 |
| 08/08/2007 | EP1814547A1 Method for treating hiv infection through co-administration of tipranavir and darunavir |
| 08/08/2007 | EP1740566B1 Hki10311129, novel antibiotic, method for producing the same and the use thereof |
| 08/08/2007 | EP1595537B1 Buccal cavity treatment composition and corresponding uses thereof |
| 08/08/2007 | EP1480671B1 Recombinant rsv virus expression systems and vaccines |
| 08/08/2007 | EP1474423B1 Heterocyclic tripeptides as hepatitis c inhibitors |
| 08/08/2007 | EP1467992B1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones |
| 08/08/2007 | EP1456382B1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 08/08/2007 | EP1432705B1 Dual action antibiotics |
| 08/08/2007 | EP1315509B1 Nitrogen oxide for use in the treatment of drug resistant organisms |
| 08/08/2007 | EP1187852B1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 08/08/2007 | EP1108035B1 Treatment of cervical cancer |
| 08/08/2007 | EP1075523B1 Structural proteins of fish pancreatic disease virus and uses thereof |
| 08/08/2007 | EP0981372B1 Compositions of antichlamydial agents for the diagnosis and management of infection caused by chlamydia |
| 08/08/2007 | CN1330758C Antifungal polypeptide and its preparation method |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN1330652C Novel carbapenem compounds |
| 08/08/2007 | CN1330647C Antibacterial heterobicyclic substituted phenyl oxazolidinones |
| 08/08/2007 | CN1330641C Activator for peroxisome proliferator-responsive receptor delta |
| 08/08/2007 | CN1330639C Crystalline pharmaceutical |
| 08/08/2007 | CN1330637C Novel compounds of family of 3-alkyl-(4,5-diphenyl-imidazol-1-yl) and their use as soothing agents |
| 08/08/2007 | CN1330376C Recombinant Borrel virus combined vaccine |
| 08/08/2007 | CN1330375C Humanized antibodies that recognize verotoxin II and cell line producing same |
| 08/08/2007 | CN1330373C Medicine composition containing alfa-interferon , adefovir and FTC |
| 08/08/2007 | CN1330372C Stabilized Inteferon compsns |
| 08/08/2007 | CN1330359C Chinese medicine preparation for treating AIDS and process thereof |
| 08/08/2007 | CN1330330C Antivirus medicinal composition, preparation method and use |
| 08/08/2007 | CN1330326C Antibicrobial and bacteria inhibiting external use medicine for gynecopathy |
| 08/08/2007 | CN1330324C Technological process of extracting effective hepatitis resisting component from Halenia comiculata plant |
| 08/08/2007 | CN1330319C Beriberi paste |
| 08/08/2007 | CN1330312C 黄芩苷软胶囊及其制备方法 Baicalin soft capsule and its preparation method |
| 08/08/2007 | CN1330307C Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/08/2007 | CN1330306C Moxifloxaci gelatin capsule and preparation process thereof |
| 08/08/2007 | CN1330294C Yinzhihuang dropping pill oriental wormwood cape jasmine and baicalin, and its preparing ad detecting method |
| 08/08/2007 | CN1330239C Synergistic microbicidal combination |
| 08/08/2007 | CN101014708A Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1 |